Profile
We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need. We are evaluating seladelpar in primary biliary cholangitis (PBC). We also have a product program in earlier development that features a unique mechanism of action with potential in chronic diseases.
Company Info
Address:
7575 Gateway Blvd
Suite 110
Newark, CA 94560 US
Telephone:
(510) 293-8800
Fax:
(510) 293-9090
Email:
info@cymabay.com